ChromaDex NAD+ “Healthy Aging” Supplement Investigation

Migliaccio & Rathod LLP is investigating ChromaDex, the maker of Tru Niagen, following consumer complaints related to aggressive NAD+ / healthy-aging marketing and recurring billing and cancellation disputes.

Reported Issues

Consumers report:

  • Marketing emphasizing “boosts NAD+” and “healthy aging” framed as clinically supported
  • Recurring charges, auto-ship disputes, and refund friction
  • Difficulty canceling subscriptions or stopping shipments
  • Customer-service delays once charges are disputed

Why Consumers Should Be Concerned

Potential legal issues include:

  • Deceptive practices, if implied aging or health benefits exceed substantiation
  • Negative-option billing and subscription-management violations
  • Unjust enrichment, where consumers pay for disputed or unwanted shipments

Signs You May Be Affected

  • Purchased ChromaDex via subscription
  • Experienced unexpected charges or refund resistance
  • Relied on “healthy aging” or clinical-support claims

If you have concerns that you have been affected and/or have experienced suspicious activity recently, we would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) 470-3520.

    The following will ask for your contact information so that we may reach you to talk about potential claims. This information is for our records only and will not be shared. By continuing, you consent to the collection of this information for these limited purposes.

    When did you last purchase this product (month and year)?
    Do you have proof of purchase for the product (receipt, email confirmation, transaction on your bank statement, etc.)?

    Please briefly describe the issue with the product.

    Would you like to join our newsletter to receive notifications about other investigations we're looking into, as well as updates on ongoing cases?

    The following will ask for your contact information so that we may reach you to talk about potential claims. This information is for our records only and will not be shared. By continuing, you consent to the collection of this information for these limited purposes.